Product NDC: | 57894-060 |
Proprietary Name: | STELARA |
Non Proprietary Name: | ustekinumab |
Active Ingredient(s): | 45 mg/.5mL & nbsp; ustekinumab |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 57894-060 |
Labeler Name: | Janssen Biotech, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125261 |
Marketing Category: | BLA |
Start Marketing Date: | 20090925 |
Package NDC: | 57894-060-04 |
Package Description: | 1 SYRINGE in 1 CARTON (57894-060-04) > .5 mL in 1 SYRINGE |
NDC Code | 57894-060-04 |
Proprietary Name | STELARA |
Package Description | 1 SYRINGE in 1 CARTON (57894-060-04) > .5 mL in 1 SYRINGE |
Product NDC | 57894-060 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ustekinumab |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20090925 |
Marketing Category Name | BLA |
Labeler Name | Janssen Biotech, Inc. |
Substance Name | USTEKINUMAB |
Strength Number | 45 |
Strength Unit | mg/.5mL |
Pharmaceutical Classes |